advanced search
2022_Stevanato_Aidaptus_Leaderboard

WEARABLES

WEARABLES
A NEW FRONTIER: SELF-ADMINISTRATION OF LYOPHILISED, LARGE-VOLUME SUBCUTANEOUS BIOLOGICS
Mehul Desai and Daniel Waites discuss the pros and cons of lyophilisation for biologic injectable drugs, and how Enable Injections’ enFuse device can provide an answer to the challenges of self-injection of large-volume and lyophilised biologics.
WEARABLES
CHRONIC PATIENTS AT THE CENTRE OF LARGE-VOLUME SC DELIVERY WITH A SUSTAINABLE ON-BODY INJECTOR
Cécile Gross and Mark Tunkel discuss the role of patient-centricity in the development of Nemera’s sustainable on-body injector platform.
HOW LIFECYCLE ASSESSMENT SUPPORTS INSIGHT-DRIVEN SUSTAINABLE DESIGN
EXPERT VIEW
Paramesh Natarajan
HOW LIFECYCLE ASSESSMENT SUPPORTS INSIGHT-DRIVEN SUSTAINABLE DESIGN
Paramesh Natarajan, Shadi Bavar and Charlie Dean present the case for using screening lifecycle assessments to lead into more detailed targeted and comprehensive lifecycle assessments focused on the areas of greatest environmental impact, using a screening lifecycle assessment of a hypothetical body-worn injector as an example.
“A CHILD IS NOT A SMALL ADULT”: CHALLENGES AND SOLUTIONS IN DEVELOPING DRUG DELIVERY DEVICES FOR CHILDREN
EXPERT VIEW
Tom Oakley
“A CHILD IS NOT A SMALL ADULT”: CHALLENGES AND SOLUTIONS IN DEVELOPING DRUG DELIVERY DEVICES FOR CHILDREN
Tom Oakley and Heather Jameson consider the main differences in developing therapies and drug delivery devices for children and babies when compared with adults.
YPSODOSE – THE CLINIC-READY 10 ML PATCH INJECTOR
WEARABLES
Christian Esser Wiesemann
Ypsomed
YPSODOSE – THE CLINIC-READY 10 ML PATCH INJECTOR
Christian Esser Wiesemann provides the latest insights into the prefilled and pre-assembled YpsoDose patch injector, which is now available for clinical trials.
PRODUCT SHOWCASE: COMPLETE SYSTEM FOR STANDARD-COMPLIANT TESTING OF WEARABLE INJECTORS
WEARABLES
Heiko Haller
ZwickRoell
PRODUCT SHOWCASE: COMPLETE SYSTEM FOR STANDARD-COMPLIANT TESTING OF WEARABLE INJECTORS
Specifically tailored to on-body delivery systems (OBDSs) / wearable injectors, ZwickRoell showcases its customised, comprehensive solution for performing functional tests in accordance with the ISO 11608-6 standard.
SUSTAINABLE DESIGN OF A DRUG DELIVERY DEVICE FOR BIOPHARMACEUTICALS
SUSTAINABILITY
Maike Wolf
Gerresheimer
SUSTAINABLE DESIGN OF A DRUG DELIVERY DEVICE FOR BIOPHARMACEUTICALS
Maike Wolf and Marie Stockton discuss how sustainability is a fundamental strategic priority for Gerresheimer. They also highlight how eco-design principles have been applied to the development of an on-body injector for subcutaneous delivery of biopharmaceuticals.
COMPARISON OF MECHATRONIC VS MECHANICAL WEARABLE DRUG DELIVERY SYSTEMS
WEARABLES
Thomas Mayer
Sonceboz
COMPARISON OF MECHATRONIC VS MECHANICAL WEARABLE DRUG DELIVERY SYSTEMS
Thomas Mayer, Nicolas Bailo and Martin Liniger highlight some of the key challenges that mechanical and mechatronic drug delivery systems must overcome when delivering large volumes of biologics subcutaneously and explain the solutions that Sonceboz has considered during the development process of the company’s large-volume injector.
EXTENDING PATIENT-FRIENDLY DRUG DELIVERY TO HIGH-VOLUME WEARABLE DEVICES
WEARABLES
Dr Iris Schnitzler
LTS
EXTENDING PATIENT-FRIENDLY DRUG DELIVERY TO HIGH-VOLUME WEARABLE DEVICES
Iris Schnitzler discusses the benefits of on-body delivery systems, including the flexibility and convenience they bring to patients managing chronic conditions, and how the Sorrel platform overcomes some of the inherent complexities and challenges of developing such a device. Dr Schnitzler then goes on to speak with Bas van Buijtenen and Andrei Yosef about the Sorrel platform and how its integration within LTS supports the company’s fundamental objectives of enabling partners and empowering patients.
THE VERTIVA™ ON-BODY DELIVERY SYSTEM: EXPANDING OPPORTUNITIES IN HOME-BASED CARE
WEARABLES
Dr Adam Stops
Stevanato Group
THE VERTIVA™ ON-BODY DELIVERY SYSTEM: EXPANDING OPPORTUNITIES IN HOME-BASED CARE
Adam Stops introduces Vertiva™, Stevanato Group’s next-generation on-body delivery system platform, and discusses how it meets the needs of pharma companies looking to deliver large-volume doses in a patient-centric manner.
Technology Showcase: CCBio’s Felice Dose – Simplifying Subcutaneous Infusion
CONNECTIVITY
Jimmy Fan
CC Bio
Technology Showcase: CCBio’s Felice Dose – Simplifying Subcutaneous Infusion
CCBio showcases Felice Dose, a revolutionary on-body injector (OBI) designed to address the challenges of traditional IV injections and SC drug administration.
INJECTING INNOVATIVE SOLUTIONS INTO CONNECTED DELIVERY DEVICES
EXPERT VIEW
Roger Bohannan
INJECTING INNOVATIVE SOLUTIONS INTO CONNECTED DELIVERY DEVICES
Roger Bohannan discusses the capabilities and design challenges of connected drug delivery devices.
INCORPORATING MOTION DESIGN AT EARLY STAGES OF WEARABLE INJECTOR DEVELOPMENT
EXPERT VIEW
Dave Beckstoffer
INCORPORATING MOTION DESIGN AT EARLY STAGES OF WEARABLE INJECTOR DEVELOPMENT
Dave Beckstoffer discusses the often overlooked importance of including motion system design considerations from the very earliest stages of wearable injector development, and how doing so can reduce costs, shorten timelines and improve patient outcomes.
DIRECTIONS FOR WEARABLE ON-BODY INJECTOR SYSTEMS AND BEYOND
EXPERT VIEW
Matt Parker
DIRECTIONS FOR WEARABLE ON-BODY INJECTOR SYSTEMS AND BEYOND
Matt Parker, Karthik Chellappan and David Cottenden discuss the current state of play for large-volume injection and look into the challenges that on-body delivery systems currently in development will need to overcome to find success in a changing marketplace.
WOULD YOU LIKE TO GO LARGE? KEY CONSIDERATIONS FOR LARGE-VOLUME INJECTORS
EXPERT VIEW
Malcolm Boyd
WOULD YOU LIKE TO GO LARGE? KEY CONSIDERATIONS FOR LARGE-VOLUME INJECTORS
Malcolm Boyd discusses the factors that need to be considered early in the development of large-volume injectors, which will have a major influence on the performance, usability and cost of a device.
REUSABLE WEARABLE INJECTORS: LESSONS FROM IN VITRO DIAGNOSTICS
EXPERT VIEW
Thomas James
REUSABLE WEARABLE INJECTORS: LESSONS FROM IN VITRO DIAGNOSTICS
Thomas James explores how insights from the development of successful in vitro diagnostic instruments can help guide the evolution of wearable injectors.
BD INNOVATION FOR SUBCUTANEOUS DELIVERY OF LARGE-VOLUME COMPLEX BIOLOGICS
WEARABLES
Beth McBride DiLauri
BD (Becton Dickinson & Company)
BD INNOVATION FOR SUBCUTANEOUS DELIVERY OF LARGE-VOLUME COMPLEX BIOLOGICS
Beth McBride DiLauri summarises the results of a clinical study on the BD Libertas™ Wearable Injector. The results position the device as a viable alternative to traditional intravenous administration.
Interview with Julien Martins & David Philbrick
INTERVIEW
Julien Martins
Paragon Medical
Interview with Julien Martins & David Philbrick
Julien Martins and David Philbrick talk exclusively with ONdrugDelivery's Guy Furness. They discuss a wide range of topics, including the services Paragon Medical provides the drug delivery industry, its wider business operations, the company’s expanded facilities in the US and Europe, and its new Advanced Surgical Innovation Center.
LESSONS FROM MARKETED MEDICAL DEVICES TO ENHANCE CONNECTED DRUG DELIVERY
CONNECTIVITY
Fallyn Flaherty-Earp
Celanese
LESSONS FROM MARKETED MEDICAL DEVICES TO ENHANCE CONNECTED DRUG DELIVERY
Fallyn Flaherty-Earp looks at what medical device manufacturers can learn from connected devices already on the market and discusses the opportunities electronic inks can provide for the development of innovative therapies for the treatment of chronic diseases.
HOW PATIENT & TREATMENT FACTORS SHAPE SUBCUTANEOUS DOSING PREFERENCES
INJECTION
Dr Andreas Schneider
Ypsomed
HOW PATIENT & TREATMENT FACTORS SHAPE SUBCUTANEOUS DOSING PREFERENCES
Andreas Schneider highlights the importance of understanding the drivers of dosing preferences when it comes to choosing the right injection device for patients. Specifically, the research summarised here studies whether and how patient characteristics and treatment attributes influence the decision to use prefilled handheld autoinjectors or large-volume wearable injectors.
ENABLING DRUG DEVELOPMENT THROUGH DRUG DELIVERY MANUFACTURING
WEARABLES
Dr Andrei Yosef
Eitan Medical
ENABLING DRUG DEVELOPMENT THROUGH DRUG DELIVERY MANUFACTURING
Andrei Yosef looks at the role of manufacturing in the development of drug delivery devices and highlights the benefits of the company’s Sorrel device, which enables pharma companies to experiment during clinical trials to ensure that drugs produced are safe and cost-effective.
PRODUCT SHOWCASE: New Requirements for Injection Devices Make Advanced Testing Solutions Necessary
INDUSTRIALISATION
Peter Schmidt
ZwickRoell
PRODUCT SHOWCASE: New Requirements for Injection Devices Make Advanced Testing Solutions Necessary
ZwickRoell showcases its advanced testing solutions for injection devices including pens, autoinjectors and on-body delivery systems.
Interview: Kymanox Executive Advisors Mathias Romacker, Fran DeGrazio & Paul Jansen
INTERVIEW
Guy Furness
Kymanox
Interview: Kymanox Executive Advisors Mathias Romacker, Fran DeGrazio & Paul Jansen
Mathias Romacker, Fran DeGrazio and Paul Jansen sit down with Guy Furness, to discuss what it is that has driven Kymanox’s rapid rise in the drug delivery space and what makes the consulting company’s model so successful, as well as to share their expertise on a variety of topics in an illuminating discussion, including connectivity, how large and small drug developers engage with consultancies, 5 mL autoinjectors and the interface between drug primary packaging and delivery devices.
LOW-COMPLEXITY, EASY-TO-USE WEARABLE INJECTION PLATFORM
WEARABLES
Jesper Roested
Subcuject
LOW-COMPLEXITY, EASY-TO-USE WEARABLE INJECTION PLATFORM
Jesper Roested discusses the increasing prevalence of biologics formulated for large-volume injections in drug development and how wearable devices, including Subcuject’s offering, may be a better solution for delivering these drugs than scaled-up conventional autoinjectors.
REDUCE PHARMA DEVELOPMENT TIME: LARGE-VOLUME SUBCUTANEOUS DELIVERY WITH THE ENFUSE<sup>®</sup>
WEARABLES
Dr Mehul Desai
Enable Injections
REDUCE PHARMA DEVELOPMENT TIME: LARGE-VOLUME SUBCUTANEOUS DELIVERY WITH THE ENFUSE®
Mehul Desai discusses how Enable Injections' enFuse® delivery system provides a flexible alternative for subcutaneous administration of high-volume therapeutics.
ANTICIPATING & MITIGATING CHALLENGES IN THE COMMERCIALISATION OF PREFILLED SYRINGES & INJECTION DEVICES – A TECHNICAL DRUG PRODUCT PERSPECTIVE
PREFILLED SYRINGES
Dr Andrea Allmendinger
ten23 health
ANTICIPATING & MITIGATING CHALLENGES IN THE COMMERCIALISATION OF PREFILLED SYRINGES & INJECTION DEVICES – A TECHNICAL DRUG PRODUCT PERSPECTIVE
Andrea Allmendinger and Hanns-Christian Mahler both at ten23 health, provide an insight into the challenges of integrated development of drug product and device design and fill-finish manufacturing operations.
BEING PREPARED FOR PHARMA INNOVATION IS KEY IN 2023
INJECTION
Victoria Morgan
West Pharmaceutical Services
BEING PREPARED FOR PHARMA INNOVATION IS KEY IN 2023
Victoria Morgan and Ana Marques Kuschel discuss three recent innovations that West Pharmaceutical Services has introduced to enable its partners to respond to specific market-driven challenges, from pandemic-driven pressures on fill-finish productivity to the underlying shift towards biologics and the accelerated growth of home-based treatment.
PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT
CONNECTIVITY
Mark Tunkel
Nemera
PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT
Mark Tunkel and Cécile Gross consider the development of connected drug delivery devices and identify how understanding the patient journey from diagnosis to treatment can be used as an early-stage decision-making tool.
DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS
CONNECTIVITY
Dr Haykel Ben Jamaa
Sensirion
DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS
Haykel Ben Jamaa explores why modern society needs digital health and how it is organised and implemented, with a focus on sensing technologies empowering digital health technologies.
ENGINEERING EXPERTISE: DESIGN FOR EXCELLENCE
INDUSTRIALISATION
Drew Jelgerhuis
Scherdel Medtec North America
ENGINEERING EXPERTISE: DESIGN FOR EXCELLENCE
Drew Jelgerhuis looks at how a design-for-excellence (DFX) systematic approach can help manufacturers achieve their objectives.
ISO 11608: WHAT THE NEW STANDARD MEANS FOR NIS MANUFACTURERS
INJECTION
Steve Augustyn
Cambridge Design Partnership
ISO 11608: WHAT THE NEW STANDARD MEANS FOR NIS MANUFACTURERS
Steve Augustyn looks at ISO 11608 and what it means for needle-based injection device manufacturers.
DESIGN STRATEGY & CONSIDERATIONS FOR COMPRESSED GAS-POWERED DEVICE APPLICATIONS
INJECTION
Jack Auld
Altaviz
DESIGN STRATEGY & CONSIDERATIONS FOR COMPRESSED GAS-POWERED DEVICE APPLICATIONS
Jack Auld discusses the potential of compressed gas as a power source for drug delivery devices, and explains how Altaviz can empower drug developers with the expertise to make full use of this exciting technology.
UNLIMITED POSSIBILITIES BY USING A GAS-PRODUCING DRY CELL
INJECTION
Marc Beutler
simatec
UNLIMITED POSSIBILITIES BY USING A GAS-PRODUCING DRY CELL
Marc Beutler and Matthias Meier discuss the myriad advantages of using a gas-producing dry cell as a drive system for injectable drug delivery devices, as compared with spring-based and electromechanical drives.
OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS
WEARABLES
Cecile Gross
Nemera
OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS
Cécile Gross discusses the unmet drug delivery needs in chronic diseases, and details how Nemera’s answer – the Symbioze® on-body injector – fulfils these needs.
THE EVOLUTION OF WEARABLES – REPRESENTING THE VOICE OF THE ENTIRE ECOSYSTEM
WEARABLES
Lauren Orme
West Pharmaceutical Services
THE EVOLUTION OF WEARABLES – REPRESENTING THE VOICE OF THE ENTIRE ECOSYSTEM
Lauren Orme, Victoria Morgan and Shari Krusniak consider the current landscape for on-body delivery systems and discuss how West Pharmaceutical Services is responding to the demands of various stakeholders.
ON-BODY DELIVERY SYSTEMS – NEWS AND TRENDS
EXPERT VIEW
Tom Oakley
ON-BODY DELIVERY SYSTEMS – NEWS AND TRENDS
Tom Oakley discusses the current state of play in the on-body delivery system space, reviews recent milestones and proposes directions for the future.
DEVELOPING AN ON-BODY PLATFORM FOR EFFECTIVE POST-OPERATIVE PAIN MANAGEMENT
WEARABLES
Paolo Golfetto
Stevanato Group
DEVELOPING AN ON-BODY PLATFORM FOR EFFECTIVE POST-OPERATIVE PAIN MANAGEMENT
Paolo Golfetto and Sheldon Moberg discuss a collaboration between Stevanato Group and Bexson Biomedical that meets an urgent unmet patient need.
A NEW MEMS ENGINE FOR LARGE-VOLUME SUBCUTANEOUS INJECTORS
WEARABLES
Dr Jiunn-Ru Lai
MicroMED Co Ltd
A NEW MEMS ENGINE FOR LARGE-VOLUME SUBCUTANEOUS INJECTORS
Jiunn-Ru Lai, Tsung-Chieh Cheng and Brian Li discuss how MicroMED’s Primary Actuator technology for driving high-volume, high-viscosity injection devices compares with current spring and motor technologies.
Top